Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients.

Trial Profile

Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Aug 2011

At a glance

  • Drugs Lamotrigine (Primary)
  • Indications Memory disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Aug 2011 Actual initiation date (Aug 2002) added and additional lead trial centre, investigator identified as reported by ClinicalTrials.gov.
    • 02 Aug 2011 Actual end date (Sep 2005) added as reported by ClinicalTrials.gov.
    • 02 Aug 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT00223262).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top